Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to fibroblast growth factor receptor 1 (ENSG00000305763)
- Target
- ENSG00000305763
- Molecular classification
- Long non-coding RNA
01
Overview
This target is a long non-coding RNA (lncRNA) transcribed antisense to the fibroblast growth factor receptor 1 (FGFR1) gene. According to gene databases and search content, there is no established evidence that this lncRNA encodes a protein or has a clear, validated biological or therapeutic function. It is classified as a non-coding RNA and not as a conventional receptor, enzyme, or therapeutic target. There is currently insufficient information to suggest that drugs interact directly with this lncRNA, and its role in disease or as a biomarker is undefined[3].\n\nKey point: This gene should not be considered a therapeutic target in the classical sense. If the intent was FGFR1 (Fibroblast growth factor receptor 1), that is a distinct and well-characterized receptor tyrosine kinase with therapeutic relevance[7]. The current entry, however, does not map to an actionable drug target.
- Other names
- Novel antisense transcript to FGFR1Antisense to FGFR1 lncRNA
02
Biological functions
Other (lncRNA with potential regulatory roles; specific functions not established)
03
Disease associations
Other (no established role; any mention would be speculative)
Beyond the preview
Go deeper on Novel transcript, antisense to fibroblast growth factor receptor 1 (ENSG00000305763).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to fibroblast growth factor receptor 1 (ENSG00000305763).